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Background
Actinomycetes may account for 10 to 30% of the total
soil rhizosphere microorganisms. The attention given to
the actinomycetes in biotechnological applications is a
result of their metabolic versatility that is accompanied
by the production of primary and secondary metabolites
of economic importance, which are a promising source of
products (e.g., antibiotics, enzyme inhibitors, antiparasitic
and anticancer agents) [1,2]. Included in this range of
compounds are secondary metabolites synthesized by
polyketide synthase (PKS) and non-ribosomal peptide
synthetase (NRPS) pathways. An effective method for
assessing the presence of these biosynthetic pathways is
the detection of PKS and NRPS genes by PCR [3,4].
Thus, this study was based on targeted analyses of 31 soil
isolate actinomycetes aiming to evaluate their antimicro-
bial potential through the NRPS and PKS-I pathways.
Methods
The antimicrobial activity was evaluated by the antagon-
ism test against two economically important phyto-
pathogens, the bacterium Xanthomonas campestris and
the fungus Thielaviopsis paradoxa, using the technique
of double layer. The X. campestris and T. paradoxa
were propagated at 28°C in YM (yeast malt) pH 6.0 and
PDB (potato dextrose broth) respectively. The results
were statistically analyzed using the Bonferroni test.
The presence of genes PKS and NRPS was evaluated
by PCR, using degenerate primers for highly conserved
regions encoding enzymes associated with biosynthesis
of polyketides and peptides.
Results and conclusions
According to the experimental results, 52% of the iso-
lates showed antimicrobial activity against at least one
of the target bacterial pathogens tested. Among these
active isolates, some belong to rare families. Thus, this
finding can be a source of novel biomolecules with anti-
microbial activity. From those isolates that presented
one of the NRPS and PKS-I genes, 75% of them showed
antagonistic activity against one of the phytopathogens
evaluated. Preliminary data on this screening demon-
strate the importance of the biotechnological potential
of these actinomycetes due to the antagonistic activity
against plant pathogens of economic interest and the
possibility of be used as biocontrol, besides offering a
strong area for metabolic research [2,5].
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